Leaderboards/Cardiovascular Issues in Pregnancy

Cardiovascular Issues in Pregnancy

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Rahul Goli
University of California, San Francisco
2
Ravindra Pawar
Dr. D. Y. Patil Medical College, Hospital and Research Centre
3
Elin Täufer Cederlöf
Uppsala University
4
Article Editorial
Unknown
5
Simon Kraler
University Hospital of Bern
6
Oktaviany Irma Wiputri
Universitas Muhammadiyah Surabaya
7
Quan Dang
The University of Sydney
8
Joanna Lewek
Medical University of Lodz
9
Rahul Sachdeva
University of British Columbia
10
Karishma P. Ramlakhan
Erasmus MC

Rising Stars Papers

1
Acute coronary syndromes: mechanisms, challenges, and new opportunities
European Heart Journal|2025
77 cit.
2
Dyslipidaemia management in pregnant patients: a 2024 update
European Heart Journal Open|2024
58 cit.
3
The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence
European Heart Journal|2025
34 cit.
4
Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score
European Heart Journal|2024
28 cit.
5
Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC)
International Journal of Cardiology|2024
27 cit.
6
Spontaneous coronary artery dissection: a clinically oriented narrative review
npj Cardiovascular Health|2024
17 cit.
7
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
Journal of Thrombosis and Haemostasis|2024
14 cit.
8
Barcelona Declaration on Open Research Information
Science Editor and Publisher|2024
13 cit.
9
Pregnancy complications and long-term risk of cardiovascular events in women with structural heart disease
Open Heart|2024
9 cit.
10
XXXI RUSSIAN NATIONAL CONGRESS "MAN AND MEDICINE". APRIL 15-18, 2024. Collection of abstracts
CARDIOVASCULAR THERAPY AND PREVENTION|2024
5 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Marysia S. Tweet
Mayo Clinic
2
Ming‐Sum Lee
Kaiser Permanente
3
Corina Thomet
University of Bern
4
Feruza Zakirova
Tashkent Pediatric Medical Institute
5
Garima Sharma
Guru Nanak Dev University
6
Thomas Stiermaier
University Hospital Schleswig-Holstein
7
Sarah Zaman
The University of Sydney
8
Ananda Kumar Mondal
Ramakrishna Mission Vidyamandira
9
Philippe Brénot
Inserm
10
Jennifer Lewey
University of Pennsylvania

Emerging Leaders Papers

1
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
European Heart Journal|2025
162 cit.
2
Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association
Circulation|2024
161 cit.
3
Association of Depression and Poor Mental Health With Cardiovascular Disease and Suboptimal Cardiovascular Health Among Young Adults in the United States
Journal of the American Heart Association|2023
121 cit.
4
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
European Heart Journal|2023
105 cit.
5
Social Determinants of Suboptimal Cardiovascular Health Among Pregnant Women in the United States
Journal of the American Heart Association|2022
59 cit.
6
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy
JAMA Cardiology|2022
59 cit.
7
Prospective Evaluation of Cardiovascular Risk 10 Years After a Hypertensive Disorder of Pregnancy
Journal of the American College of Cardiology|2022
50 cit.
8
Update on sex specific risk factors in cardiovascular disease
Frontiers in Cardiovascular Medicine|2024
46 cit.
9
Happy Heart Syndrome
JACC Heart Failure|2022
41 cit.
10
Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
Journal of the American Heart Association|2023
38 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Jolien W. Roos‐Hesselink
Erasmus MC
2
Stephen J. Wort
Royal Brompton Hospital
3
Carole A. Warnes
Mayo Clinic in Arizona
4
Nanette K. Wenger
American Heart Association
5
Gérald Simonneau
Inserm
6
Catherine Nelson‐Piercy
St Thomas' Hospital
7
Rajiv Gulati
Mayo Clinic
8
Denise Hilfiker‐Kleiner
Medizinische Hochschule Hannover
9
Salvador Moncada
Universidad Autónoma de Madrid
10
G.B. John Mancini
Cedars-Sinai Medical Center

Current Senior Leaders Papers

1
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Nature|1987
10.8k cit.
2
Vascular endothelial cells synthesize nitric oxide from L-arginine
Nature|1988
4.8k cit.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal|2022
3.7k cit.
4
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Nature|1976
3.6k cit.
5
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
New England Journal of Medicine|2005
3.5k cit.
6
Bosentan Therapy for Pulmonary Arterial Hypertension
New England Journal of Medicine|2002
2.7k cit.
7
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Nature|1986
2.4k cit.
8
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
European Heart Journal|2018
2.3k cit.
9
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Circulation|2011
2.1k cit.
10
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
Circulation|2003
2.1k cit.

Reagents for Cardiovascular Issues in Pregnancy

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 62

Bcl-3 (E2M6N) Rabbit Monoclonal Antibody

#90776$161,351
View Evidence →
Cell Signaling Technology

CABIN1 (D2B9F) Rabbit Monoclonal Antibody

#12660$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

Phospho-Tau (Thr217) (E9Y4S) Rabbit Monoclonal Antibody (Biotinylated)

#33134$587
View Evidence →
Cell Signaling TechnologyEvidence 65

DAX1 (D2F1) Rabbit Monoclonal Antibody

#13538$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

Caspase-1 (D7F10) Rabbit Monoclonal Antibody (BSA and Azide Free)

#85315$865
View Evidence →